Understanding Campylobacter in Poultry to Reduce Diarrhea in Children
Official title: Genomic Epidemiology of Campylobacter in Poultry to Enable the Effective Control of Human Campylobacteriosis in a Middle Income Country
Funded at Universidad Peruana Cayetano Heredia · NIH-11246292 · Data updated 2026-11-12
This study is looking at how Campylobacter bacteria, which can cause diarrhea in kids, behaves in chickens on different types of farms, to find out how it might be spreading and how we can better protect children from getting sick.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Universidad Peruana Cayetano Heredia NIH-funded |
| Lab location | 1 site (Lima, Peru) |
| Project start | August 1, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $49,985 |
| NIH project number | 3K43TW012298-03S1 |
| Project ID | NIH-11246292 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children under 11 years old living in low-resource settings who are at risk of Campylobacter infections.
✕Less likely to help
Patients who are not children or those living in high-resource settings may not benefit from this research.
What this research studies
This research investigates the Campylobacter bacteria, a leading cause of diarrhea in children, particularly in low-resource settings. It focuses on understanding how this pathogen behaves in poultry, both in small farms and industrial settings, to identify differences in its genetic makeup and resistance to antibiotics. By analyzing samples from chickens and linking this data to local antibiotic use, the study aims to uncover critical information that could help control Campylobacter infections in humans. The findings could lead to better prevention strategies for Campylobacteriosis, especially in vulnerable populations like children.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of diarrhea caused by Campylobacter in children, improving their health outcomes.
How similar studies have gone: Other research has shown success in understanding Campylobacter in poultry and its impact on human health, indicating that this approach is promising.
Where this research is happening
-
Universidad Peruana Cayetano Heredia
Lima, Peru Active
Researchers
- Principal investigator: Schiaffino, Francesca — Universidad Peruana Cayetano Heredia
- Study coordinator: Schiaffino, Francesca
Related research
Other NIH-funded projects on the same topics.
-
Air pollution and brain health: learning how clean air helps people with Alzheimer’s and breathing illnesses
A U.S.–Peru research effort will study how air pollution affects heart, lung, and brain health, including Alzheimer’s disease risks, with a focus on Lima, Peru.
-
One or two doses of oxfendazole compared to two doses of triclabendazole for chronic fascioliasis
This study checks whether giving one or two doses of oxfendazole works as well as the standard two-dose triclabendazole to treat chronic fascioliasis in adults and older children.
-
Understanding the causes of sudden fevers in the Andes and Amazon
This project looks for the causes of sudden fevers in people living in coastal, Andean, and Amazon regions of Peru and Ecuador to improve diagnosis and response.
-
Air pollution and brain health: linking cleaner air to better memory and heart health in Lima
A U.S.–Peru collaboration is studying how air pollution affects heart, lung, and brain health, including Alzheimer’s disease and dementia, with advanced exposure mapping in Lima.
-
ANDES: Community-driven hypertension and diabetes care in the high Andes of Peru
A community-centered project in Peru tests practical ways to diagnose and manage high blood pressure and diabetes among indigenous adults living at high altitude.
-
Oxfendazole versus triclabendazole dosing for chronic liver fluke (fascioliasis)
This compares one- and two-dose oxfendazole regimens to a two-dose triclabendazole regimen for people with chronic Fasciola (liver fluke) infection.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.